Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cytodyn Inc
CYDYCurrent price
0.13 USD
-0.005 USD (-3.85%)
Last closed
0.12 USD
Company
www.cytodyn.com
ISIN
US23283M1018
Sector
Healthcare
Industry
Biotechnology
Exchange
OTCQB
Capitalization
152 480 000 USD
Yield for 12 month
-26.43 %
1Y
3Y
5Y
10Y
15Y
CYDY
CytoDyn Inc., a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington. Address: 1111 Main Street, Vancouver, WA, United States, 98660
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
-20 633 000 USD
Current Quarter
–
Last Quarter
–
Key Figures CYDY
1 year
3 years
5 years
10 years
EBITDA
-15 970 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-49.45 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
4 USD
Revenue TTM
–
Book Value
-0.07 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-20 633 000 USD
Earnings per share
-0.02 USD
Diluted Eps TTM
-0.02 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CYDY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CYDY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CYDY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
10.8108
Enterprise Value Revenue
1010.0758
Price Sales TTM
761.8386
Enterprise Value EBITDA
-2.6641
Price Book MRQ
1066.0343
Financials CYDY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CYDY
For 52 weeks
0.11 USD
0.42 USD
50 Day MA
0.15 USD
Shares Short Prior Month
–
200 Day MA
0.15 USD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart